🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Based on literature and new information obtained in my laboratory KU Pathology & Laboratory Medicine, I propose a new model explaining how #autoantibodies may result in severe deficiency of plasma #ADAMTS13 activity in immune #thrombotic #thrombocytopenia (iTTP). jthjournal.org/article/S1538-….

Exciting news! 🎉 This month, all articles in #VoxSanguinis are free to read for everyone, thanks to Abbott 's support! Normally exclusive to ISBT members, now anyone interested can dive into the latest research. 👉 bit.ly/VoxSanguinisFe…

Teach me about this cell in the blood film of a jaundiced neonate.

A nice set of clinical calculators for determining risk in MGUS, smoldering and multiple myeloma that provides personalized risk calculations/predictions for your patients! I will be using this in the clinic! Vincent Rajkumar eatoure.github.io/#/

Is AB "universal donor" plasma evidence based or one of the most unfortunate, incorrect ideas in the history of transfusion medicine? Here are the data: linkedin.com/feed/update/ur…

So important to remember infection is leading cause if non-relapse mortality post CAR. Real need to standardise approach to prophylaxis in evidence based way. #lymsm Hartley Taylor

Hello from Kampala, Uganda! 🌍 Today, ISBT kicked off the 11th International Congress of AfSBT with an electrifying #ISBTAcademyDay all about #PatientBloodManagement. If you're at AfSBT, swing by our booth! #AfSBT2024 AfSBT

Join us for an ISBT Live Journal Club on March 13, 2024, at 3 PM CET! Hosted by Dr. Saikat Mandal, we'll discuss Myths and Facts about red blood cell transfusions with special guests Dr. Richard R. Gammon and Dr. Amita Radhakrishnan Nair. Register 👉 isbtweb.org/events/isbt-li…

Congratulations and thanks to the Team Nour AlMozain,MD, CABP, QIA نور هشام المزيّن Richard Gammon, MD Christopher Bocquet Gaurav Gupta, MD, PhD and Others🎉🎊💐

🌍 Join us today, to celebrate International Thalassaemia Day! The #BeAwareShareCare movement is rallying for change in the evolving landscape of thalassaemia treatment. Together, let's raise awareness and advocate for equitable and accessible care for all. #ThalassaemiaDay2024

There was some beautiful ever changing sunrise skies over #Aberdeen this morning ❤️ 🌅

Join us for an interactive workshop on "How to review an article?" lnkd.in/gE7s_F7j ISBT Central Office AABB Saikat Mandal Erica Wood #ISBTBarcelona #ISBTClinical Susan Brunskill

Super excited for our workshop on Artificial Intelligence and Machine Learning in Transfusion Medicine and Hematology #AIandMLinBBTM ISBT Central Office #ISBT2024 #barcelona Vitalant Johns Hopkins Medicine SIU Medicine

A publication this week has reminded me of the crucial importance of getting the #PatientInformationLeaflet (or #PIL) right and how it is so easy to get it wrong 1/7 #MethodologyMonday #94

Researchers discover new blood group system – MAL!🩸 Its identification by Ash & NHS Blood+Transplant has solved a 50 -year mystery & will help clinicians detect rare patients lacking this blood group, improving safety in transfusions. Read more brnw.ch/21wMHRG

A new cancer awareness campaign called 'Know the Signs' has been launched by Cancer Matters Wessex Knowing the signs and symptoms of cancer is key to getting an early diagnosis. Check out their webpage below and make sure you #KnowTheSigns Find out more here: cancermatterswessex.nhs.uk/know-the-signs

Studies at #MAP2024 show that whole-genome sequencing and single-cell sequencing provide insights for identifying new therapy targets, assessing minimal residual disease, and overcoming treatment resistance. #ESMODailyReporter 📌dailyreporter.esmo.org/molecular-anal…

#MAP2024: Findings from complex statistical modelling can form the basis for easy-to-use precision diagnostic and risk-stratification tools to help inform management decisions. Elli Papaemmanuil, PhD #ESMODailyReporter 📌ow.ly/mx4a50TNv9V

Nice paper using super sensitive sequencing to look at clonal haem mutations in long-term survivors of transplant (recipients+donors).. the mutations are common & clearly engraft in many cases, but don't consistently expand in recipients more than donors science.org/doi/10.1126/sc…

For many very rare diseases, we know our estimates of penetrance can be substantially inflated due to reliance on phenotypically-driven (thus highly biased) case ascertainment. SCCOHT (Small cell carcinoma of the ovary, hypercalcemic type) is a very aggressive (>70% lethality)